CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-99 Cr | ₹-99 Cr | ₹-85 Cr | ₹-100 Cr | ₹31 Cr |
What is the latest Cash Flow from Financing Activities ratio of CONCORD BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-99 Cr |
| Mar2024 | ₹-99 Cr |
| Mar2023 | ₹-85 Cr |
| Mar2022 | ₹-100 Cr |
| Mar2021 | ₹31 Cr |
How is Cash Flow from Financing Activities of CONCORD BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-99 Cr | Negative | |
| Mar2024 | ₹-99 Cr | Negative | |
| Mar2023 | ₹-85 Cr | Negative | |
| Mar2022 | ₹-100 Cr | Negative | |
| Mar2021 | ₹31 Cr | - | |
Compare Cash Flow from Financing Activities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,259.1 Cr | 21% | -2.2% | -44.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,991.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,371.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,229.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹108,441.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,407.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 21% |
-2.2% |
-44.3% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses